Numerous studies confirmed the EpCAM overexpression in ovarian carcinomas (Heinzelmann-Schwarz et al, 2004; Spizzo et al, 2006; Kobel et al, 2008), turning EpCAM into a well-established ovarian tumour marker (Spizzo et al, 2011). This evidence concerns the gene EPCAM and ovarian neoplasm.